BioRestorative Therapies (BRTX) Projected to Post Quarterly Earnings on Thursday

BioRestorative Therapies (NASDAQ:BRTXGet Free Report) is expected to issue its quarterly earnings data on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.34) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Stock Performance

NASDAQ:BRTX opened at $1.92 on Wednesday. BioRestorative Therapies has a 52 week low of $1.03 and a 52 week high of $2.55. The firm has a market cap of $13.29 million, a price-to-earnings ratio of -1.25 and a beta of 64.37. The firm’s 50-day simple moving average is $1.98 and its 200 day simple moving average is $1.72.

About BioRestorative Therapies

(Get Free Report)

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.

See Also

Earnings History for BioRestorative Therapies (NASDAQ:BRTX)

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.